Scientists have developed a molecular “clock” that could reshape how pediatricians measure and monitor childhood growth and potentially allow for an earlier diagnosis of life-altering development disorders. The research, published this week in PNAS, describes how the addition of chemical tags to DNA over time can potentially be used to screen for developmental differences and health problems in children.
Dr. Jennifer Lynett is the Technology Transfer Manager for the University Industry Liaison Office at the University of British Columbia. She is responsible for managing the technology portfolio at BC Children's Hospital and BC Women's Hospital + Health Centre.
Dr. Lynett’s research has focused on infectious diseases and immunology, and she completed her MSc at The University of Toronto before gaining her PhD from The University of British Columbia’s Department of Microbiology and Immunology. In providing technology transfer support for the Children’s & Women’s, Dr. Lynett evaluates and markets new inventions, negotiates with potential licensees and assists faculty in obtaining funding through the CIHR Proof of Principle program to commercialize their discovery.
Technology Transfer Manager, 2008-present
Technology Transfer Officer, UBC UILO, 2005-2008
Education & Training
BSc Microbiology & Immunology, UToronto; MSc Laboratory Medicine & Pathology, UToronto; PhD Microbiology & Immunology, UBC
Jennifer Lynett, PhD
Technology Transfer Manager
University of British Columbia
University Industry Liaison Office
103-6190 Agronomy Road
Canada V6T 1Z3